Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Integrated Attachment Theory

27 oktober 2026 uppdaterad av: Boston University Charles River Campus

This pilot randomized waitlist-controlled study will evaluate the feasibility and preliminary effects of a 12-week Integrated Attachment Theory (IAT) psychoeducational coaching program in adults ages 18-65 with an insecure attachment pattern identified through study screening.

Eligible participants will be randomized 1:1 to immediate IAT or a 12-week waitlist followed by IAT. The immediate group will complete in-person Boston University assessments before and after IAT; the waitlist group will complete assessments at baseline, after the 12-week waiting period, and after subsequently completing IAT.

The primary objectives are to determine whether the study procedures and intervention are feasible and to estimate the magnitude and variability of pre/post changes. The investigators hypothesize that IAT will be associated with improvement in attachment-related patterns, emotion regulation, interpersonal functioning, and well-being, together with changes in physiological and cortical responses during attachment-related emotion regulation compared with the waitlist period.

Studieöversikt

Status

Har inte rekryterat ännu

Betingelser

Intervention / Behandling

Studietyp

Interventionell

Inskrivning (Beräknad)

24

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

  • Namn: Meryem Yücel, PhD
  • Telefonnummer: 617-353-1181
  • E-post: mayucel@bu.edu

Studieorter

    • Massachusetts
      • Boston, Massachusetts, Förenta staterna, 02215
        • Boston University Center for Life Science & Engineering
        • Kontakt:
          • Meryem Yücel, PhD
          • Telefonnummer: 617-353-1181
          • E-post: mayucel@bu.edu
        • Kontakt:
          • Miray Altinkaynak, PhD MPH

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 65 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Speak and read English sufficiently to complete study questionnaires and the IAT program
  • Meets the PDS attachment-style eligibility criterion for insecure attachment
  • Able and willing to attend required in-person Boston University (BU) research visits
  • Able and willing, if assigned, to participate in the 12-week remote IAT program.

Exclusion Criteria:

  • Self-reported neurological disorder or condition
  • Self-reported psychiatric/mental-health disorder
  • Patient Health Questionnaire-9 (PHQ-9) total score >14
  • Generalized Anxiety Disorder-7 (GAD-7) total score >14
  • Failure to meet the PDS attachment-style eligibility criterion
  • Inability to complete required study procedures
  • A safety concern that makes participation inappropriate.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Stödjande vård
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Immediate Integrated Attachment Theory (IAT)

Participants randomized to this arm will immediately receive the 12 week IAT intervention.

IAT provides12 consecutive weekly remote Zoom sessions delivered by Personal Development School (PDS). Each session lasts approximately 2.5 hours with about 90 minutes of teaching plus 1 hour of supervised support. Participants will work in small breakout rooms with two participants per room during the support portion. The 12-week curriculum addresses core beliefs, relationship needs, emotional/nervous-system patterns, communication, boundaries, and behaviors. Participants will also complete approximately 10 minutes of daily skills practice/homework.

Aktiv komparator: Waitlist followed by IAT

Participants randomized to this arm will be put on a 12 week waitlist and after will receive the IAT intervention.

IAT provides12 consecutive weekly remote Zoom sessions delivered by Personal Development School (PDS). Each session lasts approximately 2.5 hours with about 90 minutes of teaching plus 1 hour of supervised support. Participants will work in small breakout rooms with two participants per room during the support portion. The 12-week curriculum addresses core beliefs, relationship needs, emotional/nervous-system patterns, communication, boundaries, and behaviors. Participants will also complete approximately 10 minutes of daily skills practice/homework.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Feasibility of IAT intervention
Tidsram: baseline through 12 weeks

Feasibility will be assessed using intervention and study completion. The number and percentage of participants assigned to IAT who complete the 12-week IAT program and the corresponding post-intervention research assessment will be calculated. Higher completion/retention rates will indicate greater feasibility.

baseline through 12 weeks
Change in attachment
Tidsram: baseline and 12 weeks

Attachment will be assessed using the self-report Personal Development School (PDS) Attachment-Style Questionnaire administered at baseline and again at the post-intervention assessment. The questionnaire characterizes participants' attachment patterns, including secure and insecure attachment styles. Change from baseline to 12 weeks will be evaluated, with movement toward greater attachment security interpreted as improvement.

baseline and 12 weeks

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in emotion regulation, measured by the Difficulties in Emotion Regulation Scale (DERS-36)
Tidsram: baseline and 12 weeks

Emotion regulation will be assessed using the 36-item self-report Difficulties in Emotion Regulation Scale (DERS-36). Items are rated on a 5-point scale from 1 (almost never) to 5 (almost always). The total score ranges from 36 to 180. Higher scores indicate greater difficulties with emotion regulation; therefore, a decrease in score from baseline indicates improvement in emotion regulation.

baseline and 12 weeks
Change in interpersonal functioning, measured by the Inventory of Interpersonal Problems-32 (IIP-32)
Tidsram: baseline and 12 weeks

Interpersonal functioning will be assessed using the 32-item self-report Inventory of Interpersonal Problems, Short Form (IIP-32). Items are rated from 0 (not at all) to 4 (very much) and assess difficulties across eight interpersonal domains. Higher scores indicate greater interpersonal difficulties; therefore, a decrease from baseline indicates improvement in interpersonal functioning.

baseline and 12 weeks
Change in well-being, measured by the WHO-5 Well-Being Index
Tidsram: baseline and 12 weeks

Well-being will be assessed using the 5-item self-report World Health Organization 5 (WHO-5) Well-Being Index. Each item is rated from 0 to 5. Raw scores range from 0 to 25 and are multiplied by 4 to yield a score from 0 to 100. Higher scores indicate better well-being; therefore, an increase from baseline indicates improvement.

baseline and 12 weeks

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Meryem Yücel, PhD, BU, Biomedical Engineering, Neurophotonics Center

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

1 december 2026

Primärt slutförande (Beräknad)

1 december 2027

Avslutad studie (Beräknad)

1 december 2027

Studieregistreringsdatum

Först inskickad

27 oktober 2026

Först inskickad som uppfyllde QC-kriterierna

27 oktober 2026

Första postat (Faktisk)

6 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

6 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

27 oktober 2026

Senast verifierad

1 oktober 2026

Mer information

Termer relaterade till denna studie

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera